Viewing Study NCT06401603


Ignite Creation Date: 2025-12-24 @ 7:45 PM
Ignite Modification Date: 2025-12-30 @ 11:36 PM
Study NCT ID: NCT06401603
Status: RECRUITING
Last Update Posted: 2025-09-11
First Post: 2024-05-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module